Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tong TS"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial.
Autorzy:
Leung WK; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
But DY; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Wong SY; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Tong TS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Liu KS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Cheung KS; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Tsang SH; Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Chok KS; Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Poon RT; Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Hung IF; Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
Journal of digestive diseases [J Dig Dis] 2018 Jun; Vol. 19 (6), pp. 369-376. Date of Electronic Publication: 2018 May 24.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Postoperative Hemorrhage/*prevention & control
Proton Pump Inhibitors/*therapeutic use
Sphincterotomy, Endoscopic/*adverse effects
Aged ; Aged, 80 and over ; Cholangiopancreatography, Endoscopic Retrograde/adverse effects ; Drug Administration Schedule ; Esomeprazole/administration & dosage ; Esomeprazole/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Postoperative Hemorrhage/etiology ; Postoperative Period ; Preoperative Care/methods ; Proton Pump Inhibitors/administration & dosage
Czasopismo naukowe
Tytuł:
Development and validation of molecular markers for characterization of Boehmeria nivea var. nivea and Boehmeria nivea var. tenacissima.
Autorzy:
Li CI; Department of Life Sciences, Tzu-Chi University, Hualien 970, Taiwan. .
Chiou SJ
Tong TS
Lee CY
Lee LT
Cheng CM
Pokaż więcej
Źródło:
Chinese medicine [Chin Med] 2010 Nov 29; Vol. 5, pp. 40. Date of Electronic Publication: 2010 Nov 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Autorzy:
Hung IF; Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.
Chan P
Leung S
Chan FS
Hsu A
But D
Seto WK
Wong SY
Chan CK
Gu Q
Tong TS
Cheung TK
Chu KM
Wong BC
Pokaż więcej
Źródło:
Helicobacter [Helicobacter] 2009 Dec; Vol. 14 (6), pp. 505-11.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Levofloxacin*
Amoxicillin/*therapeutic use
Anti-Bacterial Agents/*therapeutic use
Clarithromycin/*therapeutic use
Helicobacter Infections/*drug therapy
Ofloxacin/*therapeutic use
Adult ; Aged ; Drug Therapy, Combination/methods ; Esomeprazole/therapeutic use ; Female ; Helicobacter pylori/drug effects ; Hong Kong ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Autorzy:
Wong WM; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Gu Q
Chu KM
Yee YK
Fung FM
Tong TS
Chan AO
Lai KC
Chan CK
Wong BC
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2006 Feb 01; Vol. 23 (3), pp. 421-7.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Helicobacter pylori*
Anti-Infective Agents/*therapeutic use
Helicobacter Infections/*drug therapy
2-Pyridinylmethylsulfinylbenzimidazoles ; Adult ; Aged ; Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Drug Resistance, Bacterial ; Drug Therapy, Combination ; Female ; Hong Kong ; Humans ; Lansoprazole ; Levofloxacin ; Male ; Metronidazole/therapeutic use ; Middle Aged ; Ofloxacin/therapeutic use ; Omeprazole/analogs & derivatives ; Omeprazole/therapeutic use ; Organometallic Compounds ; Tetracycline/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Autorzy:
Wong BC; Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong. />Wong WM
Cheung KL
Tong TS
Rozen P
Young GP
Chu KW
Ho J
Law WL
Tung HM
Lai KC
Hu WH
Chan CK
Lam SK
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2003 Nov 01; Vol. 18 (9), pp. 941-6.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Occult Blood*
Colorectal Neoplasms/*diagnosis
Immunologic Tests/*methods
Adult ; Aged ; Aged, 80 and over ; China/ethnology ; Colorectal Neoplasms/ethnology ; Female ; Humans ; Male ; Mass Screening/methods ; Middle Aged ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Autorzy:
Hung WK; Department of Surgery, Kwong Wah Hospital, Hong Kong.
Wong WM
Wong GS
Yip AW
Szeto ML
Lai KC
Hu WH
Chan CK
Xia HH
Yuen MF
Fung FM
Tong TS
Ho VY
Lam SK
Wong BC
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2002 Dec; Vol. 16 (12), pp. 2067-72.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Helicobacter pylori*
Anti-Bacterial Agents/*therapeutic use
Anti-Ulcer Agents/*therapeutic use
Bismuth/*therapeutic use
Helicobacter Infections/*drug therapy
Ranitidine/*analogs & derivatives
Ranitidine/*therapeutic use
Adult ; Aged ; Amoxicillin/therapeutic use ; Anti-Bacterial Agents/adverse effects ; Bismuth/adverse effects ; Drug Therapy, Combination ; Duodenal Ulcer/drug therapy ; Duodenal Ulcer/microbiology ; Dyspepsia/drug therapy ; Dyspepsia/microbiology ; Female ; Helicobacter Infections/ethnology ; Humans ; Male ; Metronidazole/therapeutic use ; Middle Aged ; Penicillins/therapeutic use ; Ranitidine/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
Autorzy:
Wong BC; Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong. />Wong WM
Yee YK
Hung WK
Yip AW
Szeto ML
Li KF
Lau P
Fung FM
Tong TS
Lai KC
Hu WH
Yuen MF
Hui CK
Lam SK
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2001 Dec; Vol. 15 (12), pp. 1959-65.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Ulcer Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Helicobacter Infections/*drug therapy
Helicobacter pylori/*drug effects
Omeprazole/*therapeutic use
2-Pyridinylmethylsulfinylbenzimidazoles ; Adult ; Aged ; Aged, 80 and over ; Anti-Ulcer Agents/adverse effects ; Benzimidazoles/adverse effects ; Diarrhea/chemically induced ; Drug Resistance ; Drug Therapy, Combination ; Duodenal Ulcer/prevention & control ; Exanthema/chemically induced ; Female ; Helicobacter Infections/microbiology ; Helicobacter pylori/isolation & purification ; Humans ; Male ; Middle Aged ; Omeprazole/adverse effects ; Proton-Translocating ATPases/antagonists & inhibitors ; Rabeprazole ; Stomach Ulcer/prevention & control ; Time Factors ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies